Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Association of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies

  • Forat-Yazdi, Mohammad (Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences and Health Services) ;
  • Gholi-Nataj, Mohsen (Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences and Health Services) ;
  • Neamatzadeh, Hossein (Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences and Health Services) ;
  • Nourbakhsh, Parisa (Department of Medical Immunology, Kermanshah University of Medical Sciences and Health Services) ;
  • Shaker-Ardakani, Hossein (Shahid Sadoughi Training Hospital, Shahid Sadoughi University of Medical Sciences and Health Services)
  • Published : 2015.04.29
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Non-synonymous polymorphisms in XRCC1 hase been shown to reduce effectiveness of DNA repair and be associated with risk of certain cancers. In this study we aimed to clarify any association between XRCC1 Arg399Gln and colorectal cancer (CRC) risk by performing a meta-analysis of published case-control studies. Materials and Methods: PubMed and Google Scholar were searched to explore the association between XRCC1 and CRC. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to estimate the association strength. Publication bias was assessed by Egger's and Begg's tests. Results: Up to January 2015, 35 case control studies involving 9,114 CRC cases and 13,948 controls were included in the present meta-analysis. The results showed that the Arg399Gln polymorphism only under an allele genetic model was associated with CRC risk (A vs. G: OR 0.128, 95% CI 0.119-0.138, p<0.001). Also, this meta-analysis suggested that the XRCC1 Arg399Gln polymorphism might associated with susceptibility to CRC in Asians (A vs G: OR 0.124, 95% CI 0.112-0.138, p<0.001) and Caucasian (A vs G: OR 0.132, 95% CI 0.119-0.146, p<0.001) only under an allele genetic model. Conclusions: This meta-analysis confirms the association between XRCC1 Arg399Gln polymorphism and CRC risk and suggests that the heterogeneity is not strongly modified by ethnicity and deviation from the Hardy-Weinberg equilibrium.

Keywords

References

  1. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al (2000). Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of earlyonset colorectal carcinoma in Egypt. Cancer Lett, 159, 79-86. https://doi.org/10.1016/S0304-3835(00)00537-1
  2. Brevik A, Joshi AD, Corral R, et al (2010). Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers nof the effect of diets high in red meat. Cancer Epidemiol Biomarkers Prev, 19, 3167-73. https://doi.org/10.1158/1055-9965.EPI-10-0606
  3. Canbay E, Cakmakoglu B, Zeybek U, et al (2011). Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Curr Med Res Opin, 27, 1295-302. https://doi.org/10.1185/03007995.2011.573544
  4. Curtin K, Samowitz WS, Wolff RK, et al (2009). Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev, 18, 3384-8. https://doi.org/10.1158/1055-9965.EPI-09-0955
  5. Engin AB, Karahalil B, Karakaya AE, et al (2011) Association between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population. Arh Hig Rada Toksikol, 62, 207-214.
  6. Gao CM, Ding JH, Li SP, et al (2014). Polymorphisms in XRCC1 gene, alcohol drinking, and risk of colorectal cancer: a casecontrol study in Jiangsu Province of China. Asian Pac J Cancer Prev, 14, 6613-8.
  7. Gil J, Ramsey D, Stembalska A, et al (2012). The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol Biol Rep, 39, 527-534. https://doi.org/10.1007/s11033-011-0767-5
  8. Gsur A, Bernhart K, Baierl A, et al (2011). No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk. Cancer Epidemiol, 35, 38-41. https://doi.org/10.1016/j.canep.2011.03.005
  9. Guo LY, Jin XP, Niu W, et al (2012). Association of XPD and XRCC1 Genetic Polymorphisms with Hepatocellular Carcinoma Risk. Asian Pac J Cancer Prev, 13, 4423-6. https://doi.org/10.7314/APJCP.2012.13.9.4423
  10. Hong YC, Lee KH, Kim WC, et al (2005). Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer. Int J Cancer, 116, 428-32. https://doi.org/10.1002/ijc.21019
  11. Improta G, Sgambato A, Bianchino G, et al (2008). Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population. Anticancer Res, 28, 2941-6.
  12. Jin MJ, Chen K, Zhang Y, et al (2007). Correlations of single nucleotide polymorphisms of DNA repair gene XRCC1 to risk of colorectal cancer. Ai Zheng, 26, 274-279.
  13. Jelonek K, Gdowicz-Klosok A, Pietrowska M, et al (2010). Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet, 51, 343-52. https://doi.org/10.1007/BF03208865
  14. Khan NP, Pandith AA, Yousuf A, et al (2013). The XRCC1 Arg399Gln gene polymorphism and risk of colorectal cancer: a study in Kashmir. Asian Pac J Cancer Prev, 14, 6779-82. https://doi.org/10.7314/APJCP.2013.14.11.6779
  15. Kasahara M, Osawa K, Yoshida K, et al (2008). Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. J Exp Clin Cancer Res, 27, 49. https://doi.org/10.1186/1756-9966-27-49
  16. Krupa R, Blasiak J (2004). An association of polymorphism of DNA repair genes XRCC1 and XRCC3 with colorectal cancer. J Exp Clin Cancer Res, 23, 285-294.
  17. Ladiges WC (2006). Mouse models of XRCC1 DNA repair polymorphisms and cancer. Oncogene, 25, 1612-19. https://doi.org/10.1038/sj.onc.1209370
  18. Li W, Yang F, Gui Y, Bian J (2014). DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta-analysis. Oncol Lett, 8, 1725-30.
  19. Liu L, Miao L, Ji G, et al (2013). Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies. Mol Biol Rep, 40, 3943-52. https://doi.org/10.1007/s11033-012-2471-5
  20. Lu M, Sun L, Yang J, (2013). Letter to the editor: Obvious association between XRCC1 Arg399Gln polymorphism and colorectal cancer in East Asians. Int J Colorectal Dis, 28, 1449-50. https://doi.org/10.1007/s00384-012-1614-4
  21. Magaji BA, Moy FM, Roslani C, et al (2014). Descriptive epidemiology of colorectal cancer in university Malaya medical centre, 2001 to 2010. Asian Pac J Cancer Prev, 15, 6059-64. https://doi.org/10.7314/APJCP.2014.15.15.6059
  22. Mao D, Zhang Y, Lu H, et al (2013). Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk. Tumour Biol, 34, 2529-38. https://doi.org/10.1007/s13277-013-0760-9
  23. Martinez-Balibrea E, Abad A, Aranda E, et al (2008). Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. Eur J Cancer, 44, 1229-37. https://doi.org/10.1016/j.ejca.2008.03.025
  24. Mehrabani1 D, Shamsdin SA, Dehghan A, et al (2014). Clinical significance of serum vascular endothelial growth factor and complement 3a levels in patients with colorectal cancer in Southern Iran. Asian Pac J Cancer Prev, 15, 9713-7. https://doi.org/10.7314/APJCP.2014.15.22.9713
  25. Moreno V, Gemignani F, Landi S, et al (2006). Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res, 2, 2101-8.
  26. Muniz-Mendoza R, Ayala-Madrigal ML, Partida-Perez M, et al (2012). MLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer. Genet Mol Res, 11, 2315-20. https://doi.org/10.4238/2012.June.27.6
  27. Nassiri M, Kooshyar MM, Roudbar Z, et al (2013). Genes and SNPs associated with non-hereditary and hereditary colorectal cancer. Asian Pac J Cancer Prev, 14, 5609-14. https://doi.org/10.7314/APJCP.2013.14.10.5609
  28. Omranipour R (2014). Prevalence of Local Recurrence of Colorectal Cancer at the Iranian Cancer Institute. Asian Pac J Cancer Prev, 15, 8587-9. https://doi.org/10.7314/APJCP.2014.15.20.8587
  29. Tian Z, Li YL, Liu JG (2013). XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population. Mol Biol Rep, 40, 4147-51. https://doi.org/10.1007/s11033-012-2463-5
  30. Pardini B, Naccarati A, Novotny J, et al (2008). DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res, 638, 146-53. https://doi.org/10.1016/j.mrfmmm.2007.09.008
  31. Poomphakwaen K, Promthet S, Suwanrungruang K, et al (2014). XRCC1 gene polymorphism, diet and risk of colorectal cancer in Thailand. Asian Pac J Cancer Prev, 15, 7479-86. https://doi.org/10.7314/APJCP.2014.15.17.7479
  32. Procopciuc LM, Osian G (2013). Lys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancerrisk and different stages of carcinomas. Chirurgia (Bucur), 108, 711-8.
  33. Przybylowska K, Kabzinski J, Sygut A, et al (2013). An association selected polymorphisms of XRCC1, OGG1 and MUTYH gene and the level of efficiency oxidative DNA damage repair with a risk of colorectal cancer. Mutat Res 745, 6-15.
  34. Qin CJ, Xu KW, Chen ZH, et al (2015). XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis. Tumour Biol. [Epub ahead of print]
  35. Salanti G, Sanderson S, Higgins JP (2005). Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med, 7, 13-20. https://doi.org/10.1097/01.GIM.0000151839.12032.1A
  36. Santos JC, Funck A, Silva-Fernandes IJ, et al (2014). Effect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer. Int J Mol Sci, 15, 17333-43. https://doi.org/10.3390/ijms151017333
  37. Sliwinski T, Krupa R, Wisniewska-Jarosinska M, et al (2008) No association between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and colorectal cancer risk and progression in a Polish population. Exp Oncol, 30, 253-254.
  38. Skjelbred CF, Saebø M, Wallin H, et al (2006). Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer, 6, 67. https://doi.org/10.1186/1471-2407-6-67
  39. Song HN, Liu XL, Er YX, et al (2008). The correlative study of the XRCC1 gene haplotype and risk of colorectal cancer in China. J Qiqihar Medi Colle, 29, 2957-60.
  40. Stern MC, Conti DV, Siegmund KD, et al (2007). DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev, 16, 2363-2372. https://doi.org/10.1158/1055-9965.EPI-07-0268
  41. Wang J, Zhao Y, Jiang J, et al (2010). Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population. J Cancer Res Clin Oncol, 136, 1517-25. https://doi.org/10.1007/s00432-010-0809-8
  42. Wang B, Wang D, Huang G, et al (2010). XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis, 25, 313-21. https://doi.org/10.1007/s00384-009-0866-0
  43. Wu W, Wu Y, Wang M, et al (2013). Meta-analysis of the association between the XRCC1 gene R399Q polymorphism and colorectal cancer: an update. Int J Colorectal Dis, 28, 1453-4. https://doi.org/10.1007/s00384-012-1627-z
  44. Yeh CC, Hsieh LL, Tang R, et al (2005) MS-920: DNA repair gene polymorphisms, diet and colorectal cancer risk in Taiwan. Cancer Lett, 224, 279-288. https://doi.org/10.1016/j.canlet.2005.01.029
  45. Yin G, Morita M, Ohnaka K, et al (2012). Genetic polymorphisms of XRCC1, alcohol consumption, and the risk of colorectal cancer in Japan. J Epidemiol, 22, 64-71. https://doi.org/10.2188/jea.JE20110059
  46. Zeng FR, Ling Y, Yang J, et al (2013). X-ray repair crosscomplementing group 1 Arg399Gln gene polymorphism and susceptibility tocolorectal cancer:a meta-analysis. Tumour Biol, 34, 555-63. https://doi.org/10.1007/s13277-012-0581-2
  47. Zhao Y, Deng X, Wang Z, et al (2012). Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk of colorectal cancer in Chinese population. Asian Pac J Cancer Prev, 13, 665-9. https://doi.org/10.7314/APJCP.2012.13.2.665
  48. Zhang SH, Wang LA, Li Z, et al (2014). APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans. World J Gastroenterol, 20, 8700-8. https://doi.org/10.3748/wjg.v20.i26.8700
  49. Zhu C, Zhang Y, Bao Q, et al (2011). The study on the relationship between XRCC1 gene polymorphisms and the susceptibility of colorectal cancer. Chin J Dig, 31, 450-4.

Cited by

  1. Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India vol.37, pp.7, 2016, https://doi.org/10.1007/s13277-015-4780-5
  2. Lack of correlation between X-ray repair cross-complementing group 1 gene polymorphisms and the susceptibility to colorectal cancer in a Malaysian cohort vol.26, pp.6, 2017, https://doi.org/10.1097/CEJ.0000000000000336